Il y a eu 50 transactions d'initiés récentes enregistrées pour Monopar Therapeutics Inc. (MNPR), dont 23 achats et 23 ventes. Le total des achats d'initiés s'élève à $10.38M et le total des ventes d'initiés à $36.81M.
Les initiés notables ayant une activité récente comprennent Robinson Chandler, Cittadine Andrew, Rodriguez Susan. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — MNPR
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-31 |
Robinson Chandler |
Chief Executive Officer |
Retenue Fiscale RSU |
1,972 |
$54.79 |
$108.05K |
90,478 |
| 2026-03-31 |
Cittadine Andrew |
Chief Operating Officer |
Exercice d'Options (Vente) |
3,514 |
- |
- |
44,753 |
| 2026-03-02 |
Rodriguez Susan |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-02 |
Rodriguez Susan |
Ccso |
Attribution de RSU |
48,728 |
$53.47 |
$2.61M |
48,728 |
| 2026-01-01 |
Rioux Patrice |
Other: Acting Chief Medical Officer |
Attribution de RSU |
2,000 |
$65.30 |
$130.6K |
2,000 |
| 2025-12-31 |
Robinson Chandler |
Chief Executive Officer |
Retenue Fiscale RSU |
2,558 |
$65.30 |
$167.04K |
85,718 |
| 2025-12-31 |
Cittadine Andrew |
Chief Operating Officer |
Exercice d'Options (Vente) |
4,326 |
- |
- |
48,267 |
| 2025-12-26 |
Vu Quan Anh |
Chief Financial Officer |
Achat Informatif |
1,500 |
$69.95 |
$104.93K |
1,500 |
| 2025-12-18 |
Klausner Arthur J |
Director |
Vente Informative |
461 |
$68.09 |
$31.39K |
8,762 |
| 2025-12-16 |
Klausner Arthur J |
Director |
Autre (Achat) |
7,710 |
- |
- |
13,883 |
| 2025-12-16 |
Hendricks Diane |
10 Percent Owner |
Autre (Vente) |
43,499 |
- |
- |
567,580 |
| 2025-12-02 |
Klausner Arthur J |
Director |
Attribution de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Starr Christopher M |
Director |
Attribution de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Tsuchimoto Kim R |
Director |
Attribution de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Anderson Raymond |
Director |
Attribution de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Robinson Chandler |
Chief Executive Officer |
Attribution de RSU |
16,753 |
$75.94 |
$1.27M |
16,753 |
| 2025-12-02 |
Cittadine Andrew |
Chief Operating Officer |
Attribution de RSU |
8,969 |
$75.94 |
$681.11K |
8,969 |
| 2025-12-02 |
Vu Quan Anh |
Chief Financial Officer |
Attribution de RSU |
7,135 |
$75.94 |
$541.83K |
7,135 |
| 2025-12-02 |
Talukdar Lavina |
Director |
Attribution de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-09-30 |
Robinson Chandler |
Chief Executive Officer |
Exercice d'Options (Vente) |
8,726 |
- |
- |
72,599 |
| 2025-09-30 |
Cittadine Andrew |
Chief Operating Officer |
Exercice d'Options (Vente) |
4,327 |
- |
- |
38,674 |
| 2025-09-24 |
Tactic Pharma Llc |
10 Percent Owner |
Vente Informative |
550,229 |
$63.61 |
$35M |
272,026 |
| 2025-07-14 |
Starr Christopher M |
Director |
Exercice d'Options (ITM) |
16,800 |
$0.01 |
$84.00 |
- |
| 2025-07-14 |
Tsuchimoto Kim R |
Director |
Exercice d'Options (ITM) |
4,704 |
$0.01 |
$23.52 |
- |
| 2025-07-14 |
Robinson Chandler |
Chief Executive Officer |
Exercice d'Options (ITM) |
16,800 |
$0.01 |
$84.00 |
- |
| 2025-06-30 |
Robinson Chandler |
Chief Executive Officer |
Retenue Fiscale RSU |
5,865 |
$35.78 |
$209.85K |
73,472 |
| 2025-06-30 |
Cittadine Andrew |
Chief Operating Officer |
Exercice d'Options (Vente) |
6,863 |
- |
- |
43,001 |
| 2025-04-02 |
Tactic Pharma Llc |
10 Percent Owner |
Vente Informative |
33,334 |
$35.00 |
$1.17M |
822,255 |
| 2025-03-31 |
Robinson Chandler |
Chief Executive Officer |
Retenue Fiscale RSU |
1,204 |
$36.41 |
$43.84K |
65,993 |
| 2025-03-31 |
Cittadine Andrew |
Chief Operating Officer |
Retenue Fiscale RSU |
744 |
$36.41 |
$27.09K |
41,985 |
| 2025-03-04 |
Klausner Arthur J |
Director |
Attribution de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Starr Christopher M |
Director |
Attribution de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Tsuchimoto Kim R |
Director |
Attribution de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Anderson Raymond |
Director |
Attribution de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Robinson Chandler |
Chief Executive Officer |
Retenue Fiscale RSU |
1,759 |
$31.70 |
$55.76K |
63,091 |
| 2025-03-04 |
Cittadine Andrew |
Chief Operating Officer |
Attribution de RSU |
43,445 |
$31.70 |
$1.38M |
43,445 |
| 2025-03-04 |
Talukdar Lavina |
Director |
Attribution de RSU |
5,683 |
$31.70 |
$180.15K |
5,683 |
| 2025-03-03 |
Vu Quan Anh |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-03-03 |
Vu Quan Anh |
Chief Financial Officer |
Attribution de RSU |
25,000 |
$30.93 |
$773.25K |
25,000 |
| 2025-02-21 |
Talukdar Lavina |
Director |
Inconnu |
- |
- |
- |
14,001 |
| 2025-01-28 |
Robinson Chandler |
Chief Executive Officer |
Autre (Achat) |
62,815 |
- |
- |
62,815 |
| 2025-01-01 |
Rioux Patrice |
Other: Acting Chief Medical Officer |
Attribution de RSU |
2,000 |
$22.00 |
$44K |
2,000 |
| 2024-12-31 |
Robinson Chandler |
Chief Executive Officer |
Exercice d'Options (Vente) |
4,895 |
- |
- |
24,879 |
| 2024-12-31 |
Cittadine Andrew |
Chief Operating Officer |
Exercice d'Options (Vente) |
1,790 |
- |
- |
11,074 |
| 2024-12-09 |
Tacticgem Llc |
10 Percent Owner |
Autre (Vente) |
1,433,334 |
- |
- |
- |
| 2024-10-28 |
Radhakrishnan Karthik |
Chief Financial Officer |
Achat Informatif |
1,550 |
$16.25 |
$25.19K |
1,550 |
| 2024-09-30 |
Robinson Chandler |
Chief Executive Officer |
Exercice d'Options (Vente) |
4,895 |
- |
- |
29,774 |
| 2024-09-30 |
Cittadine Andrew |
Chief Operating Officer |
Exercice d'Options (Vente) |
1,791 |
- |
- |
12,864 |
| 2024-07-01 |
Radhakrishnan Karthik |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-07-01 |
Radhakrishnan Karthik |
Chief Financial Officer |
Attribution de RSU |
125,000 |
$0.74 |
$92.68K |
125,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi